Civic Intelligence

Clinical Research Foundation Inc.

990 • Fiscal year 2015 • EIN 61-1144514

Jan 01, 2015 to Dec 31, 2015 • Filed on Apr 26, 2016

Organization ProfileN/A
800 Zorn Avenue Suite 151Louisville, KY 40206

(502) 287-6260

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

46th percentile

0.03x

Higher debt load relative to assets than 46% of similar nonprofits.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2015

Liabilities / Revenue

46th percentile

0.03x

Higher debt load relative to revenue than 46% of similar nonprofits.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2015

Net Margin

77th percentile

19%

Higher net margin than 77% of similar nonprofits.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2015

Top Officer Pay

59th percentile

$35,706

Higher top officer pay than 59% of similar nonprofits.

Top officer pay equals 5.1% of source-year revenue.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2015

Asset Growth

82nd percentile

27%

Faster asset growth than 82% of similar nonprofits.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2014 to 2015

Revenue Growth

86th percentile

46%

Faster revenue growth than 86% of similar nonprofits.

2015 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2014 to 2015

Balance Sheet
Liabilities / Assets46th percentile

Assets

Up

$733,292

Up $154,409 (+27%) from 2014

Net Assets

Up

$711,439

Up $134,681 (+23%) from 2014

Liabilities

Up

$21,853

Up $19,728 (+928%) from 2014

Revenue And Expenses
Liabilities / Revenue46th percentileNet Margin77th percentile

Revenue

Up

$705,979

Up $220,899 (+46%) from 2014

Expenses

Down

$571,298

Down $13,038 (-2.2%) from 2014

Net Income

Up

$134,681

Up $233,937 (+236%) from 2014

Historical Trend

Balance Sheet Trend

Asset Growth82nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2010: $381,617Liabilities 2010: $0Net Assets 2010: $381,6172010Assets 2011: $495,033Liabilities 2011: $0Net Assets 2011: $495,0332011Assets 2012: $702,584Liabilities 2012: $0Net Assets 2012: $702,5842012Assets 2013: $674,250Liabilities 2013: $0Net Assets 2013: $674,2502013Assets 2014: $578,883Liabilities 2014: $2,125Net Assets 2014: $576,7582014Assets 2015: $733,292Liabilities 2015: $21,853Net Assets 2015: $711,4392015Assets 2016: $863,667Liabilities 2016: $25,392Net Assets 2016: $838,2752016Assets 2017: $672,546Liabilities 2017: $48,481Net Assets 2017: $624,0652017Assets 2018: $482,383Liabilities 2018: $39,322Net Assets 2018: $443,0612018Assets 2019: $326,853Liabilities 2019: $12,293Net Assets 2019: $314,5602019Assets 2020: $244,533Liabilities 2020: $5,615Net Assets 2020: $238,9182020Assets 2021: $267,190Liabilities 2021: $0Net Assets 2021: $267,1902021Assets 2022: $232,461Liabilities 2022: $0Net Assets 2022: $232,4612022Assets 2023: $256,437Liabilities 2023: $2,730Net Assets 2023: $253,7072023Assets 2024: $395,422Liabilities 2024: $65,069Net Assets 2024: $330,3532024

Highlighted filing

2015

Assets$733,292
Liabilities$21,853
Net Assets$711,439
Open 2015 Filing

Operations Trend

Revenue Growth86th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KExpenses 2010: $343,0872010Expenses 2011: $365,6792011Expenses 2012: $388,6532012Revenue 2013: $641,413Expenses 2013: $669,747Net Income 2013: -$28,3342013Revenue 2014: $485,080Expenses 2014: $584,336Net Income 2014: -$99,2562014Revenue 2015: $705,979Expenses 2015: $571,298Net Income 2015: $134,6812015Revenue 2016: $537,657Expenses 2016: $410,821Net Income 2016: $126,8362016Revenue 2017: $195,155Expenses 2017: $409,365Net Income 2017: -$214,2102017Revenue 2018: $264,093Expenses 2018: $445,097Net Income 2018: -$181,0042018Revenue 2019: $259,788Expenses 2019: $388,388Net Income 2019: -$128,6002019Revenue 2020: $449,134Expenses 2020: $523,458Net Income 2020: -$74,3242020Revenue 2021: $628,030Expenses 2021: $599,758Net Income 2021: $28,2722021Revenue 2022: $388,144Expenses 2022: $394,996Net Income 2022: -$6,8522022Revenue 2023: $330,716Expenses 2023: $309,470Net Income 2023: $21,2462023Revenue 2024: $375,042Expenses 2024: $287,830Net Income 2024: $87,2122024

Highlighted filing

2015

Revenue$705,979
Expenses$571,298
Net Income$134,681
Open 2015 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Signed
Apr 26, 2016
Return Version
2015v2.1
Gross Receipts
$705,979
Mission and Program Overview

Mission

Clinical Research Foundation, Inc. (CRF) promotes quality scientific research to improve the medical treatment, general health, and quality of life for our nation's veterans by providing a flexible funding mechanism to Robley Rex VA Medical Center researchers for non-VA funded studies or trials

Clinical research foundation, inc. Exists to facilitate research at the robley rex va medical center in louisville, ky.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$142,500$526,077▲ $383,577
Savings and Temporary Cash Investments$400,000$152,000▼ $248,000
Pledges and Grants Receivable$34,063$53,137▲ $19,074
Prepaid Expenses and Deferred Charges$2,320$2,078▼ $242
Total Assets$578,883$733,292▲ $154,409
Liabilities
Accounts Payable and Accrued Expenses$2,125$21,853▲ $19,728
Total Liabilities$2,125$21,853▲ $19,728
Net Assets / Fund Balance
Unrestricted Net Assets$576,758$711,439▲ $134,681
Total Net Assets Fund Balance$576,758$711,439▲ $134,681
Total Liabilities and Net Assets / Fund Balance$578,883$733,292▲ $154,409
Compensation and Service Providers
Top Officer Pay59th percentile

Employees

NameTitleFull / Part TimeBaseTotal
Kimberly KelleyExecutive DiPT$35,706$35,706

Board Members and Trustees

NameTitle
Eleanor Lederer MdChair
Bill Seiller AttorneyDirector
Lora Johnson PhdDirector
Martha SpurlockDirector
Martin TraxlerDirector
Mary Lee Rothschild MdDirector
Sathya Krishnasamy MdDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$806
Program Service Revenue
$703,269
Investment Income
$1,904
Other Revenue
$0
All Other Contributions
$806
Change in Net Assets
$134,681

Audited Revenue Reconciliation

Revenue per Audited Statements
$705,979
Total Revenue per Audited Statements
$705,979
Total Revenue per Form 990
$705,979
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$300,286
Salaries, Compensation, and Employee Benefits$271,012
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$202,789$11,656-$214,445
Fees for Services Other$52,045--$52,045
Current Officers, Directors, Trustees, and Key Employees-$35,706-$35,706
Conferences and Meetings$21,272$5,244-$26,516
Payroll Taxes$16,980$3,881-$20,861
Travel$7,670$900-$8,570
Other Expenses$18,526$2,831-$2,831
Insurance-$1,940-$1,940
Office Expenses$41$1,634-$1,675
Fees for Services Accounting-$1,075-$1,075
All Other Expenses$120--$120
Advertising-$30-$30
Total Functional Expenses$502,926$68,372$0$571,298

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$571,298
Total Expenses per Audited Statements$571,298
Total Expenses per Form 990$571,298
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The form 990 is reviewed and approved by the entire board at a scheduled meeting.”

Form 990, Page 6, Part VI, Line 12C

“On an annual basis the board of directors/officers/employees must answer and sign a specific questionnaire designed to highlight any potential confilict of interest. The questionnaire is reviewed and housed by crf administration.”

Form 990, Page 6, Part VI, Line 15A

“Compensation determination for the executive director must be reviewed and approved by the board of directors.”

Form 990, Page 6, Part VI, Line 19

“UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Clinical Research Foundation Inc
EIN
61-1144514
Phone
5022876260
Address
800 ZORN AVENUE SUITE 151, LOUISVILLE, KY 40206

Signing Officer

Name
Kimberly Kelley
Title
Executive Director
Phone
5022876260
Signed
2016-04-26

Organization Details

Principal Officer
Kimberly Kelley
Formed
1988
Legal Domicile
Ky
Voting Board Members
7
Independent Board Members
7
Employees
18
Volunteers
6

Preparer

Firm
Baldwin Cpas Pllc
Address
943 S 1ST STREET, LOUISVILLE, KY 40203
Preparer
Barbara Lasky
Phone
5025849793
Supplemental Narrative

Additional Explanations

Form 990, Page 2, Part III, Line 4C

“Suicidology annual 2014 and 2015 conferences and the military executive advisory board. A treatment manual is in the final review stages before disseminating to other va facilities.”

Form 990, Page 2, Part III, Line 4D

“Garrison, md, et al (u of l award) - necrotizing entercolitis/peritoneal resuscitation, tissue injury. Expense 62,503. Revenue 83,134. Mokshagundam, md (boehringer ingelheim) (novo nordisk) - diabetes clinical trials. Expense 23,665. Revenue 27,945. Matheson, phd (kentucky organ donor affiliates) - induced cell dysfunction in brain death. Expense 30,503. Revenue 33,979. Nakamatsu (cempra) - community-acquired bacterial pneumonia drug therapy clinical trial. Expense 0. Revenue 10,775 wagner, md (amgen) - cholesterol reduction drug therapy clinical trial. Expense 215. Revenue 7,500. Julio ramirez, m.d. ( u of l/ nih award) niaid study of hiv. Expense 75,497. Revenue 0. M. Stoddard, m.d. (stodnov, stodcirt, stodeman, stodglor, stodpar, stodrelax) - cardiovascular studies expense 30,801. Revenue 66,130. Other project support - vmu, review.com, pharm, projects < 1,000. Expense 7,062. Revenue 0.”

Financial Statement Notes

Schedule D, Page 3, Part X

“Management has concluded that any tax positions that would not meet the more-likely-than-not criterion of fasb asc 740-10 would be immaterial to the financial statements taken as a whole. Accordingly, the accompanying financial statements do not include any provision for uncertain tax positions, and no related interest or penalties have been recorded in the statement of revenue, expenses and other changes in net assets or accrued in the statement of assets and net assets. Federal and state tax returns of the entity are generally open to examination by the relevant taxing authorities for a period of three years from the date the returns are filed.”

Raw XML Appendix351 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02125
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt021853
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0CLINICAL RESEARCH FOUNDATION, INC. EXISTS TO FACILITATE RESEARCH AT THE ROBLEY REX VA MEDICAL CENTER IN LOUISVILLE, KY.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt030
IRS990/AdvertisingGrp/TotalAmt030
IRS990/AllOtherContributionsAmt0806
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0120
IRS990/AllOtherExpensesGrp/TotalAmt0120
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum05022876260
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0800 ZORN AVENUE STE 151
IRS990/BooksInCareOfDetail/USAddress/CityNm0LOUISVILLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0KY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd040206
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0142500
IRS990/CashNonInterestBearingGrp/EOYAmt0526077
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt035706
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt035706
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt05244
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt021272
IRS990/ConferencesMeetingsGrp/TotalAmt026516
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0806
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt01904
IRS990/CYOtherExpensesAmt0300286
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0703269
IRS990/CYRevenuesLessExpensesAmt0134681
IRS990/CYSalariesCompEmpBnftPaidAmt0271012
IRS990/CYTotalExpensesAmt0571298
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0705979
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0PI-KRISHNASAMY, SATHYA, M.D. (KRIS4191, KRISDEV, KRISNOVO, KRISTAIN) -- DIABETES AND RELATED CARDIOVASCULAR COMPLICATIONS ARE MAJOR CAUSES OF MORBIDITY AND MORTALITY AMONG VETERANS. THE NOVO STUDIES ARE WELL DESIGNED INTERNATIONAL LONGITUDINAL RANDOMIZED CLINICAL TRIALS MEASURING CV OUTCOMES IN VETERANS WITH TYPE 2 DIABETES. SUCH STUDIES ALLOW OUR DIABETIC PATIENTS, UNDER CLOSELY MONITORED CARE, TO RECEIVE THE LATEST DRUGS AND TREATMENT INFORMATION CONCERNING THEIR DISEASE. IT ALSO SHEDS LIGHT INTO DISEASE SPECIFIC PATTERNS WHICH MAY BE UNIQUE TO OUR VETERAN POPULATION WHICH ENHANCES OUR KNOWLEDGE TO IMPROVE VETERANS' OVERALL HEALTH.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt018
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0116232
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt01075
IRS990/FeesForServicesAccountingGrp/TotalAmt01075
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt052045
IRS990/FeesForServicesOtherGrp/TotalAmt052045
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt725.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0ELEANOR LEDERER MD
IRS990/Form990PartVIISectionAGrp/PersonNm1MARTIN TRAXLER
IRS990/Form990PartVIISectionAGrp/PersonNm2MARY LEE ROTHSCHILD MD
IRS990/Form990PartVIISectionAGrp/PersonNm3LORA JOHNSON PHD
IRS990/Form990PartVIISectionAGrp/PersonNm4SATHYA KRISHNASAMY MD
IRS990/Form990PartVIISectionAGrp/PersonNm5MARTHA SPURLOCK
IRS990/Form990PartVIISectionAGrp/PersonNm6BILL SEILLER ATTORNEY
IRS990/Form990PartVIISectionAGrp/PersonNm7KIMBERLY KELLEY
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt735706
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7EXECUTIVE DI
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01988
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd0true
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0705979
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IndependentAuditFinclStmtInd0true
IRS990/IndependentVotingMemberCnt07
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt01940
IRS990/InsuranceGrp/TotalAmt01940
IRS990/InvestmentIncomeGrp/ExclusionAmt01904
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01904
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt06
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0KY
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0CLINICAL RESEARCH FOUNDATION, INC. EXISTS TO FACILITATE RESEARCH AT THE ROBLEY REX VA MEDICAL CENTER IN LOUISVILLE, KY.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0576758
IRS990/NetAssetsOrFundBalancesEOYAmt0711439
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt01634
IRS990/OfficeExpensesGrp/ProgramServicesAmt041
IRS990/OfficeExpensesGrp/TotalAmt01675
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherExpensesGrp/Desc0PROJECT COSTS
IRS990/OtherExpensesGrp/Desc1ANIMAL COSTS
IRS990/OtherExpensesGrp/Desc2MEMBERSHIP DUES
IRS990/OtherExpensesGrp/Desc3PAYROLL SERVICES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03475
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt12831
IRS990/OtherExpensesGrp/ProgramServicesAmt0183483
IRS990/OtherExpensesGrp/ProgramServicesAmt118526
IRS990/OtherExpensesGrp/TotalAmt0183483
IRS990/OtherExpensesGrp/TotalAmt118526
IRS990/OtherExpensesGrp/TotalAmt23475
IRS990/OtherExpensesGrp/TotalAmt32831
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt011656
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0202789
IRS990/OtherSalariesAndWagesGrp/TotalAmt0214445
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt03881
IRS990/PayrollTaxesGrp/ProgramServicesAmt016980
IRS990/PayrollTaxesGrp/TotalAmt020861
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt034063
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt053137
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt02320
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt02078
IRS990/PrincipalOfficerNm0KIMBERLY KELLEY
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0621500
IRS990/ProgramServiceRevenueGrp/Desc0PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0703269
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0703269
IRS990/ProgSrvcAccomActy2Grp/Desc0PI-NAKAMATSU, RAUL, M.D. (NAKPFI) -- TO PROVIDE THE LOUISVILLE VA MEDICAL CENTER A BETTER UNDERSTANDING OF THE SIGNIFICANCE OF PNEUMOCOCCAL PNEUMONIA IN THEIR PATIENT POPULATION. SPECIFICALLY THE STUDY WILL DETERMINE EARLY AND LATE IMPROVEMENTS OR POSSIBLE COMPLICATIONS AND THEIR FREQUENCY IN HOSPITALIZED ADULT PATIENTS WITH PNEUMONIA TO ADDRESS SOME OF THE GAPS IN CURRENT KNOWLEDGE. PNEUMOCOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA REPRESENTS A SIGNIFICANT CAUSE OF ILLNESS IN OLDER ADULTS, BOTH ACTIVE AND INACTIVE DUE TO NATURALLY WEAKENING OF THE IMMUNE SYSTEM THAT OCCURS WITH AGING.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt051657
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt0137788
IRS990/ProgSrvcAccomActy3Grp/Desc0PI - JOHNSON, LORA, PHD (JOMO) -- THIS PROJECT ENTITLED "SUICIDE RISK ASSESSMENTS IN SUICIDE-SPECIFIC GROUP THERAPY FOR VETERANS: A PILOT STUDY" IS A RESEARCH AWARD FROM THE MILITARY SUICIDE RESEARCH CONSORTIUM. HYPOTHESIS - ADDING A STRUCTURED ASSESSMENT/TRACKING PROCEDURE TO SUICIDE- SPECIFIC GROUP THERAPY FOR SUICIDAL VETERANS WILL RESULT IN BETTER CLINICAL ATTENDANCE AND SATISFACTION WHEN COMPARED TO THE SAME GROUP THERAPY INTERVENTION USING EXISTING INFORMAL ASSESSMENT OF SUICIDE RISK. THE STRUCTURED ASSESSMENT TOOL USED WAS THE COLLABORATIVE ASSESSMENT AND MANAGEMENT OF SUICIDALITY. THE STUDY CONCLUDED IN FALL OF 2015, FINAL PAPER STILL FORTHCOMING. PRELIMINARY FINDINGS WERE PUBLISHED WITH MILITARY BEHAVIORAL HEALTH AND PRESENTATIONS HAVE BEEN PRESENTED AT THE AMERICAN SUICIDOLOGY ANNUAL 2014 AND 2015 CONFERENCES AND THE MILITARY EXECUTIVE ADVISORY BOARD. A TREATMENT MANUAL IS IN THE FINAL REVIEW STAGES BEFORE DISSEMINATING TO OTHER VA FACILITIES.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0104791
IRS990/ProgSrvcAccomActy3Grp/RevenueAmt0127981
IRS990/ProgSrvcAccomActyOtherGrp/Desc0GARRISON, MD, ET AL (U OF L AWARD) - NECROTIZING ENTERCOLITIS/PERITONEAL RESUSCITATION, TISSUE INJURY. EXPENSE 62,503. REVENUE 83,134. MOKSHAGUNDAM, MD (BOEHRINGER INGELHEIM) (NOVO NORDISK) - DIABETES CLINICAL TRIALS. EXPENSE 23,665. REVENUE 27,945. MATHESON, PHD (KENTUCKY ORGAN DONOR AFFILIATES) - INDUCED CELL DYSFUNCTION IN BRAIN DEATH. EXPENSE 30,503. REVENUE 33,979. NAKAMATSU (CEMPRA) - COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA DRUG THERAPY CLINICAL TRIAL. EXPENSE 0. REVENUE 10,775 WAGNER, MD (AMGEN) - CHOLESTEROL REDUCTION DRUG THERAPY CLINICAL TRIAL. EXPENSE 215. REVENUE 7,500. JULIO RAMIREZ, M.D. ( U OF L/ NIH AWARD) NIAID STUDY OF HIV. EXPENSE 75,497. REVENUE 0. M. STODDARD, M.D. (STODNOV, STODCIRT, STODEMAN, STODGLOR, STODPAR, STODRELAX) - CARDIOVASCULAR STUDIES EXPENSE 30,801. REVENUE 66,130. OTHER PROJECT SUPPORT - VMU, REVIEW.COM, PHARM, PROJECTS < 1,000. EXPENSE 7,062. REVENUE 0.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0230246
IRS990/ProgSrvcAccomActyOtherGrp/RevenueAmt0229862
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0100
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt02010
IRS990/PYOtherExpensesAmt0218743
IRS990/PYProgramServiceRevenueAmt0482970
IRS990/PYRevenuesLessExpensesAmt0-99256
IRS990/PYSalariesCompEmpBnftPaidAmt0365593
IRS990/PYTotalExpensesAmt0584336
IRS990/PYTotalRevenueAmt0485080
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0134681
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0207638
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0400000
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0152000
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0LOUISVILLE
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0KY
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0ROBLEY REX VA MEDICAL CENTER
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/ExpensesSubtotalAmt0571298
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/RevenueSubtotalAmt0705979
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0MANAGEMENT HAS CONCLUDED THAT ANY TAX POSITIONS THAT WOULD NOT MEET THE MORE-LIKELY-THAN-NOT CRITERION OF FASB ASC 740-10 WOULD BE IMMATERIAL TO THE FINANCIAL STATEMENTS TAKEN AS A WHOLE. ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT INCLUDE ANY PROVISION FOR UNCERTAIN TAX POSITIONS, AND NO RELATED INTEREST OR PENALTIES HAVE BEEN RECORDED IN THE STATEMENT OF REVENUE, EXPENSES AND OTHER CHANGES IN NET ASSETS OR ACCRUED IN THE STATEMENT OF ASSETS AND NET ASSETS. FEDERAL AND STATE TAX RETURNS OF THE ENTITY ARE GENERALLY OPEN TO EXAMINATION BY THE RELEVANT TAXING AUTHORITIES FOR A PERIOD OF THREE YEARS FROM THE DATE THE RETURNS ARE FILED.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE D, PAGE 3, PART X
IRS990ScheduleD/TotalExpensesPerForm990Amt0571298
IRS990ScheduleD/TotalRevenuePerForm990Amt0705979
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0705979
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt0571298
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0SUICIDOLOGY ANNUAL 2014 AND 2015 CONFERENCES AND THE MILITARY EXECUTIVE ADVISORY BOARD. A TREATMENT MANUAL IS IN THE FINAL REVIEW STAGES BEFORE DISSEMINATING TO OTHER VA FACILITIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1GARRISON, MD, ET AL (U OF L AWARD) - NECROTIZING ENTERCOLITIS/PERITONEAL RESUSCITATION, TISSUE INJURY. EXPENSE 62,503. REVENUE 83,134. MOKSHAGUNDAM, MD (BOEHRINGER INGELHEIM) (NOVO NORDISK) - DIABETES CLINICAL TRIALS. EXPENSE 23,665. REVENUE 27,945. MATHESON, PHD (KENTUCKY ORGAN DONOR AFFILIATES) - INDUCED CELL DYSFUNCTION IN BRAIN DEATH. EXPENSE 30,503. REVENUE 33,979. NAKAMATSU (CEMPRA) - COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA DRUG THERAPY CLINICAL TRIAL. EXPENSE 0. REVENUE 10,775 WAGNER, MD (AMGEN) - CHOLESTEROL REDUCTION DRUG THERAPY CLINICAL TRIAL. EXPENSE 215. REVENUE 7,500. JULIO RAMIREZ, M.D. ( U OF L/ NIH AWARD) NIAID STUDY OF HIV. EXPENSE 75,497. REVENUE 0. M. STODDARD, M.D. (STODNOV, STODCIRT, STODEMAN, STODGLOR, STODPAR, STODRELAX) - CARDIOVASCULAR STUDIES EXPENSE 30,801. REVENUE 66,130. OTHER PROJECT SUPPORT - VMU, REVIEW.COM, PHARM, PROJECTS < 1,000. EXPENSE 7,062. REVENUE 0.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE FORM 990 IS REVIEWED AND APPROVED BY THE ENTIRE BOARD AT A SCHEDULED MEETING.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3ON AN ANNUAL BASIS THE BOARD OF DIRECTORS/OFFICERS/EMPLOYEES MUST ANSWER AND SIGN A SPECIFIC QUESTIONNAIRE DESIGNED TO HIGHLIGHT ANY POTENTIAL CONFILICT OF INTEREST. THE QUESTIONNAIRE IS REVIEWED AND HOUSED BY CRF ADMINISTRATION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4COMPENSATION DETERMINATION FOR THE EXECUTIVE DIRECTOR MUST BE REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 2, PART III, LINE 4C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4D
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0KY
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0578883
IRS990/TotalAssetsEOYAmt0733292
IRS990/TotalAssetsGrp/BOYAmt0578883
IRS990/TotalAssetsGrp/EOYAmt0733292
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt0806
IRS990/TotalEmployeeCnt018
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt068372
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0502926
IRS990/TotalFunctionalExpensesGrp/TotalAmt0571298
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt02125
IRS990/TotalLiabilitiesEOYAmt021853
IRS990/TotalLiabilitiesGrp/BOYAmt02125
IRS990/TotalLiabilitiesGrp/EOYAmt021853
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0576758
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0711439
IRS990/TotalOtherProgSrvcExpenseAmt0230246
IRS990/TotalOtherProgSrvcRevenueAmt0229862
IRS990/TotalProgramServiceExpensesAmt0502926
IRS990/TotalProgramServiceRevenueAmt0703269
IRS990/TotalReportableCompFromOrgAmt035706
IRS990/TotalRevenueGrp/ExclusionAmt01904
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0703269
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0705979
IRS990/TotalVolunteersCnt06
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0578883
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0733292
IRS990/TravelGrp/ManagementAndGeneralAmt0900
IRS990/TravelGrp/ProgramServicesAmt07670
IRS990/TravelGrp/TotalAmt08570
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt0576758
IRS990/UnrestrictedNetAssetsGrp/EOYAmt0711439
IRS990/UponRequestInd0X
IRS990/VotingMembersGoverningBodyCnt07
IRS990/VotingMembersIndependentCnt07
IRS990/WebsiteAddressTxt0N/A
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02016-09-27 15:27:22Z
ReturnHeader/BusinessOfficerGrp/PersonNm0KIMBERLY KELLEY
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum05022876260
ReturnHeader/BusinessOfficerGrp/SignatureDt02016-04-26
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CLINICAL RESEARCH FOUNDATION INC
ReturnHeader/Filer/BusinessNameControlTxt0CLIN
ReturnHeader/Filer/EIN0611144514
ReturnHeader/Filer/PhoneNum05022876260
ReturnHeader/Filer/USAddress/AddressLine1Txt0800 ZORN AVENUE SUITE 151
ReturnHeader/Filer/USAddress/CityNm0LOUISVILLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0KY
ReturnHeader/Filer/USAddress/ZIPCd040206
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0201416603
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BALDWIN CPAS PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0943 S 1ST STREET
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LOUISVILLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0KY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd040203
ReturnHeader/PreparerPersonGrp/PhoneNum05025849793
ReturnHeader/PreparerPersonGrp/PreparationDt02016-04-27
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0BARBARA LASKY
ReturnHeader/ReturnTs02016-04-27T09:16:16-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02015-01-01
ReturnHeader/TaxPeriodEndDt02015-12-31
ReturnHeader/TaxYr02015

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2015 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$733,292
Liabilities
$21,853
Net assets
$711,439
Revenue
$705,979
Expenses
$571,298
Net income
$134,681
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.95$0.65$3.30$3.75$2.88$0.87
2023Detailed filing. Detailed filing data is available for this year.$2.56$0.03$2.54$3.31$3.09$0.21
2022Detailed filing. Detailed filing data is available for this year.$2.32$0.00$2.32$3.88$3.95$0.07
2021Detailed filing. Detailed filing data is available for this year.$2.67$0.00$2.67$6.28$6.00$0.28
2020Detailed filing. Detailed filing data is available for this year.$2.45$0.06$2.39$4.49$5.23$0.74
2019Summary only. Only limited summary data is available for this year.$3.27$0.12$3.15$2.60$3.88$1.29
2018Detailed filing. Detailed filing data is available for this year.$4.82$0.39$4.43$2.64$4.45$1.81
2017Summary only. Only limited summary data is available for this year.$6.73$0.48$6.24$1.95$4.09$2.14
2016Detailed filing. Detailed filing data is available for this year.$8.64$0.25$8.38$5.38$4.11$1.27
2015Detailed filing. Detailed filing data is available for this year.$7.33$0.22$7.11$7.06$5.71$1.35
2014Detailed filing. Detailed filing data is available for this year.$5.79$0.02$5.77$4.85$5.84$0.99
2013Detailed filing. Detailed filing data is available for this year.$6.74$0.00$6.74$6.41$6.70$0.28
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.03$0.00$7.03$3.89
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.95$0.00$4.95$3.66
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.82$0.00$3.82$3.43